121 related articles for article (PubMed ID: 1932745)
1. Isolation from commercial aurintricarboxylic acid of the most effective polymeric inhibitors of von Willebrand factor interaction with platelet glycoprotein Ib. Comparison with other polyanionic and polyaromatic polymers.
Weinstein M; Vosburgh E; Phillips M; Turner N; Chute-Rose L; Moake J
Blood; 1991 Nov; 78(9):2291-8. PubMed ID: 1932745
[TBL] [Abstract][Full Text] [Related]
2. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets.
Phillips MD; Moake JL; Nolasco L; Turner N
Blood; 1988 Dec; 72(6):1898-903. PubMed ID: 3264193
[TBL] [Abstract][Full Text] [Related]
3. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
[TBL] [Abstract][Full Text] [Related]
4. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
Azzam K; Cissé-Thiam M; Drouet L
Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
[TBL] [Abstract][Full Text] [Related]
5. Unexpected effects of aurin tricarboxylic acid on human platelets.
Kinlough-Rathbone RL; Packham MA
Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
[TBL] [Abstract][Full Text] [Related]
6. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.
Alevriadou BR; Moake JL; Turner NA; Ruggeri ZM; Folie BJ; Phillips MD; Schreiber AB; Hrinda ME; McIntire LV
Blood; 1993 Mar; 81(5):1263-76. PubMed ID: 8443388
[TBL] [Abstract][Full Text] [Related]
7. M(r) 6,400 aurin tricarboxylic acid directly activates platelets.
Guo Z; Weinstein MJ; Phillips MD; Kroll MH
Thromb Res; 1993 Jul; 71(1):77-88. PubMed ID: 8367837
[TBL] [Abstract][Full Text] [Related]
8. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
Hoylaerts MF
Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
[TBL] [Abstract][Full Text] [Related]
9. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
10. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
Chow TW; Hellums JD; Moake JL; Kroll MH
Blood; 1992 Jul; 80(1):113-20. PubMed ID: 1611079
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of glycoprotein Ib affect the inhibition by aurintricarboxylic acid of the von Willebrand factor dependent platelet aggregation.
Boncler MA; Golanski J; Paczuski R; Watala C
J Mol Med (Berl); 2002 Dec; 80(12):796-801. PubMed ID: 12483465
[TBL] [Abstract][Full Text] [Related]
12. Isolation of the von Willebrand factor domain interacting with platelet glycoprotein Ib, heparin, and collagen and characterization of its three distinct functional sites.
Mohri H; Yoshioka A; Zimmerman TS; Ruggeri ZM
J Biol Chem; 1989 Oct; 264(29):17361-7. PubMed ID: 2477370
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo.
Kawasaki T; Kaku S; Kohinata T; Sakai Y; Taniuchi Y; Kawamura K; Yano S; Takenaka T; Fujimura Y
Am J Hematol; 1994 Sep; 47(1):6-15. PubMed ID: 8042618
[TBL] [Abstract][Full Text] [Related]
14. A new binding assay of von Willebrand factor and glycoprotein Ib using solid-phase biotinylated platelets.
Hayata K; Nakayama T; Matsushita T; Sakano K
J Pharmacol Sci; 2008 Oct; 108(2):217-21. PubMed ID: 18845909
[TBL] [Abstract][Full Text] [Related]
15. Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury.
Kornblith LZ; Robles AJ; Conroy AS; Hendrickson CM; Calfee CS; Fields AT; Callcut RA; Cohen MJ
J Trauma Acute Care Surg; 2018 Nov; 85(5):873-880. PubMed ID: 29985231
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
17. Aurin tricarboxylic acid inhibits adhesion of platelets to subendothelium.
Owens MR; Holme S
Thromb Res; 1996 Jan; 81(2):177-85. PubMed ID: 8822132
[TBL] [Abstract][Full Text] [Related]
18. Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
Strony J; Phillips M; Brands D; Moake J; Adelman B
Circulation; 1990 Mar; 81(3):1106-14. PubMed ID: 2306818
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
Mazurov AV; Vinogradov DV; Vlasik TN; Repin VS; Booth WJ; Berndt MC
Thromb Res; 1991 Jun; 62(6):673-84. PubMed ID: 1718052
[TBL] [Abstract][Full Text] [Related]
20. Adhesion of blood platelets is inhibited by VCL, a recombinant fragment (leucine504 to lysine728) of von Willebrand factor.
Sixma JJ; Ijsseldijk MJ; Hindriks G; van Zanten GH; Gorecki M; Panet A; Garfinkel LI; de Groot PG
Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):64-71. PubMed ID: 8548428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]